Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients
NCT ID: NCT00433134
Last Updated: 2009-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2006-06-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To define the causes and issues associated with nonadherence in our population
Hypothesis:
There is a difference in the rates and patterns of adherence to transplant medications versus other medications also taken by transplant patients
Methods:
1. A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence.
2. A brief review of demographics and pertinent laboratory information at the same encounter
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring and Improving Medication Adherence in Kidney Transplant Patients
NCT02639949
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
NCT03977051
Improving Adherence in Nonadherent Kidney Transplant Patients
NCT03892317
Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants
NCT03540121
Prediction of Medication Compliance Following Renal Transplantation
NCT00148187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To determine the prevalence of nonadherence in our population
2. To assess possible causes of nonadherence and correlate those causes with demographic information and clinical findings
3. To assess for differences between adherence with immunosuppressive regime versus adherence with other medications (for hypertension, diabetes, hypercholesterolemia)
Methods:
1. A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence
2. A brief review of demographics and pertinent laboratory information at the same encounter
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adherence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* More than 4.5 years post transplant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York - Downstate Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SUNY Downstate MC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariana Markell, MD
Role: PRINCIPAL_INVESTIGATOR
State University of New York - Downstate Medical Center
Sima Terebelo, MPH, RPA-C
Role: PRINCIPAL_INVESTIGATOR
State University of New York - Downstate Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SUNY Downstate Medical Center
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.